# Recipharm Uppsala AB – FDA Inspection, Jun 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/recipharm-uppsala-ab/3cf2f7c1-c42d-4c91-b17e-8bcde754b9ef
Source feed: FDA_Inspections

> FDA inspection 1028387 of Recipharm Uppsala AB, June 30, 2017. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028387
- Company Name: Recipharm Uppsala AB
- Inspection Date: 2017-06-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1301930 - 2024-04-17
- FDA Inspection 1210857 - 2021-08-26
- [FDA Inspection 869566 - 2014-03-14](https://www.keypedia.com/records/fda_inspections/recipharm-uppsala-ab/ffd92d1c-9662-4635-94ff-0d3dfafc5d64)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.keypedia.com/companies/recipharm-uppsala-ab/2b5e3c54-3326-4cac-8628-6dc7236eb53f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c